LASIK. What the literature actually says.
Twenty-five years and millions of treated eyes. A short, honest read on what the studies report — efficacy, new visual symptoms, ectasia risk, and what is still under study. Every claim links to the paper.
What it is.
LASIK — laser in situ keratomileusis — corrects refractive error by reshaping the corneal stroma under a hinged flap. A femtosecond laser cuts the flap, an excimer laser ablates the underlying stromal bed to a calibrated profile, the flap is repositioned, and the patient is sitting upright within minutes. The procedure has been performed in commercial volumes since 1999 and is one of the most-studied elective interventions in modern medicine.
The technique exists in its current form because two questions have been answered repeatedly in the literature: how to achieve 20/20 uncorrected acuity safely in low-to-moderate myopia, and how to screen the small subset of corneas where the procedure should not be offered. Modern LASIK with wavefront-optimised or topography-guided ablation is the answer to the first question. Tomography-based ectasia screening is the answer to the second.
The technique.
An ESCRS-credentialed refractive surgeon reviews tomography (Scheimpflug or OCT), pachymetry, manifest and cycloplegic refraction, and tear-film status before any incision is planned. The pre-operative screen is the procedure — the laser step is the easy part.
Flap creation uses a femtosecond laser at calibrated thickness (typically 100-110 microns) with a planar geometry that preserves residual stromal bed thickness above 280 microns after ablation. The excimer laser delivers a wavefront-optimised or topography-guided ablation profile based on pre-op aberrometry — Schwind Amaris 1050RS runs at 1,050 Hz with active eye-tracking on six axes, which is what compresses ablation time to under 30 seconds per eye for a typical correction.
Total room time is 14 minutes per eye in our protocol. The patient sits up between eyes, walks to the recovery suite, and is given preservative-free lubricant drops, a topical antibiotic, and a topical steroid taper. Vision is functional within 4-6 hours; uncorrected acuity stabilises over 1-7 days for most refractive errors.
What the outcomes data shows.
Efficacy in modern LASIK is very high. A 2021 meta-analysis by Cheng et al. of seven randomised trials (n=1,168 eyes) reports that both wavefront-optimised and topography-guided ablation achieve excellent predictability, with topography-guided producing marginally fewer surgically induced higher-order aberrations. A 12-year follow-up cohort published in PMC reports 88% of LASIK-treated eyes within ±1.00 D of target at 10 years — efficacy decreases slightly over time due to myopic regression, but the safety profile remains excellent.
Patient-reported outcomes are now well-mapped by the FDA's PROWL-1 and PROWL-2 studies (Eydelman et al., 2017, n=574). More than 95% of participants were satisfied with their vision post-operatively. The honest counterweight in the same dataset: 43-46% of participants reported a new visual symptom (glare, halo, starburst, double images) at three months, and dry-eye symptoms — though typically improving overall — were a recurrent complaint in a substantial minority through 6 months.
Ectasia — progressive corneal steepening after surgery — is the rare but serious adverse outcome. Randleman et al. (Ophthalmology, 2008) developed the Ectasia Risk Score System from 171 case-control eyes, identifying abnormal topography, residual stromal bed thickness, age, preoperative corneal thickness, and refractive magnitude as the dominant risk factors. Subsequent validation studies report imperfect sensitivity (70-80%), which is why modern screening relies on tomography (Pentacam, Scheimpflug) plus epithelial mapping rather than the original score alone.
What we still study.
Long-term refractive stability beyond 15 years for high-myopia corrections is still being characterised — most published cohorts run to 10-12 years, and ageing presbyopia is now the dominant uncorrected-acuity variable for patients treated in their thirties. The genetic and tear-film predictors of new-onset chronic dry eye after LASIK remain incompletely understood; some patients with normal pre-op Schirmer's and tear break-up time still develop sustained symptoms.
Ectasia screening continues to evolve. Modern multi-modal screening (corneal tomography + biomechanics + epithelial mapping) is more sensitive than the original Randleman score, but no single algorithm catches every at-risk cornea. This is why a borderline case is referred to PRK or ICL rather than offered LASIK — the screen is the safety net.
The Hektor protocol.
Pre-operative screening is non-negotiable: Pentacam tomography, ocular surface assessment, manifest plus cycloplegic refraction. Borderline tomography or thin residual stromal bed predictions result in a no — we offer PRK or ICL instead, or we send a clean decline.
We use the Schwind Amaris 1050RS with wavefront-optimised ablation as our default profile. 14 minutes per eye, recovery suite by 09:30, discharge with medication by midday. A 24-hour video check is built into the package, with structured reviews at 1 week, 1 month, 3 months, and 12 months.
- ·Stable refraction for 12+ months (≤0.50 D change in the past year)
- ·Myopia up to −10.00 D, hyperopia up to +5.00 D, astigmatism up to −6.00 D
- ·Normal corneal tomography (Pentacam Scheimpflug, no keratoconus signatures)
- ·Adequate residual stromal bed prediction (≥280 μm after ablation)
- ·Age 18+ (typically 21+ for stability margin)
- ·Adequate tear film (Schirmer + TBUT within reference range)
- ·Free of active ocular surface disease or systemic autoimmune flare
- —Keratoconus or forme fruste keratoconus on tomography
- —Insufficient residual stromal bed prediction or thin pre-op corneas
- —Significant dry eye disease (uncontrolled MGD, Sjögren's, severe SPK)
- —Active uveitis, untreated glaucoma, or retinal pathology requiring intervention
- —Pregnancy or breastfeeding (refraction can shift transiently)
- —Unrealistic expectations — especially patients over 40 expecting freedom from reading glasses
Thin corneas (<500 μm central) or borderline ablation budget: we consider PRK or ICL instead — both safer choices when LASIK's residual-bed prediction is marginal.
Mildly asymmetric tomography with borderline BAD-D / ARTmax: always referred to PRK or ICL, never offered LASIK. The screen is the safety net; we do not push it.
Presbyopia onset (typically 40+): monovision strategy is discussed honestly. Many patients choose binocular distance correction plus reading glasses — that combination has the cleanest patient-reported outcomes in our audit.
Recovery, by milestone.
Compared to alternatives.
SMILE is flapless — slightly faster dry-eye recovery and marginally more biomechanically stable. LASIK has 20+ years more outcomes data, easier retreatment via flap lift, and corrects hyperopia (SMILE does not). Choice is patient-specific; we offer both.
PRK has no flap, so no flap complications. Long-term safety is essentially equivalent to LASIK. Recovery is slower (3–5 days of significant discomfort, weeks of haze risk). For thin corneas or borderline topography, PRK is the safer choice and our default referral.
For corneas unsuitable for laser — thin, very high prescription, irregular topography — ICL is the better option. Reversible. Long-term endothelial cell loss (~1.1% / year vs ~0.5% control) is a real consideration disclosed at consultation.PMID 33729361
Lifestyle decision, not a safety one. LASIK does not eliminate the need for reading glasses after age 40 — presbyopia is a different optical problem. The honest framing: LASIK reclaims roughly 25–30 hours / year of lens-care time.
- ·Bilateral LASIK procedure (both eyes)
- ·Pre-op screen: Pentacam tomography, OCT, manifest + cycloplegic refraction, tear-film assessment
- ·Schwind Amaris 1050RS laser time (wavefront-optimised or topography-guided)
- ·Post-op medication kit (preservative-free lubricants, antibiotic, steroid taper, eye shields)
- ·24-hour video check with the operating surgeon before your flight
- ·Structured follow-up at week 1, month 1, month 3, and month 12
- ·Translator (8 languages) + airport transfers + optional hotel night
UK/US/EU figures are typical-range benchmarks for premium private refractive clinics with equivalent laser platforms (Schwind Amaris, WaveLight EX500, Zeiss MEL 90) — not Hektor quotes. Sourced from publicly published 2024–2025 clinic price pages.
Our Istanbul figure is a locked bilateral package — one number, paid once. No per-eye surcharge, no upgrade fees for topography-guided ablation when indicated, no post-op product upsell.
Common questions.
Is LASIK safe in the long term?+
Will I be free of glasses forever?+
Does LASIK hurt?+
What if I have dry eye already?+
Can LASIK be redone if regression occurs?+
What if my prescription is too high?+
Will I get the new visual symptoms PROWL describes?+
Why is Istanbul cheaper than the UK or US for LASIK?+
What if my candidacy is borderline?+
How long do I need to stay in Istanbul?+
Book this procedure.
A specialist-signed plan in 24 hours, with the bibliography for your specific candidacy attached. The deposit holds the day; the package is one number.
Book a day